Therefore, a mammary specific Cd9 knockout mouse model or syngeneic engrafting of Cd9−/− PyMT tumors into Cd9+/+ mice may further aid in elucidating the role of CD9 in breast cancer progression and metastasis. This evidence concerns the gene CD9 and breast carcinoma.